- Home
- UTMD vs CATX Comparison
UTMD vs CATX Comparison
Compare UTMD & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- CATX
- Stock Information
- Founded
- UTMD 1978
- CATX 1983
- Country
- UTMD United States
- CATX United States
- Employees
- UTMD N/A
- CATX N/A
- Industry
- UTMD Medical/Dental Instruments
- CATX Medical/Dental Instruments
- Sector
- UTMD Health Care
- CATX Health Care
- Exchange
- UTMD Nasdaq
- CATX Nasdaq
- Market Cap
- UTMD 171.3M
- CATX 182.9M
- IPO Year
- UTMD N/A
- CATX N/A
- Fundamental
- Price
- UTMD $53.60
- CATX $2.34
- Analyst Decision
- UTMD
- CATX Strong Buy
- Analyst Count
- UTMD 0
- CATX 10
- Target Price
- UTMD N/A
- CATX $13.89
- AVG Volume (30 Days)
- UTMD 15.6K
- CATX 619.9K
- Earning Date
- UTMD 04-29-2025
- CATX 05-12-2025
- Dividend Yield
- UTMD 2.27%
- CATX N/A
- EPS Growth
- UTMD N/A
- CATX N/A
- EPS
- UTMD 3.78
- CATX N/A
- Revenue
- UTMD $39,273,000.00
- CATX $1,454,000.00
- Revenue This Year
- UTMD N/A
- CATX N/A
- Revenue Next Year
- UTMD N/A
- CATX N/A
- P/E Ratio
- UTMD $14.24
- CATX N/A
- Revenue Growth
- UTMD N/A
- CATX 1.40
- 52 Week Low
- UTMD $51.26
- CATX $1.60
- 52 Week High
- UTMD $77.33
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- UTMD 48.81
- CATX 51.17
- Support Level
- UTMD $51.80
- CATX $2.18
- Resistance Level
- UTMD $54.78
- CATX $2.65
- Average True Range (ATR)
- UTMD 1.22
- CATX 0.16
- MACD
- UTMD 0.35
- CATX 0.02
- Stochastic Oscillator
- UTMD 66.48
- CATX 56.25
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.